Skip to main content

Press Releases and Ad-hoc Announcements

21 December 2020
AH: Heidelberg Pharma AG Receives Shareholder Loan Based on an Existing Financing Commitment
PDF
12 November 2020
PR: Heidelberg Pharma will Present at German Equity Forum and Provides Update on Partner Activities for its Legacy Assets
PDF
05 November 2020
PR: Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2020
PDF
08 October 2020
PR: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2020
PDF
29 September 2020
AH: Heidelberg Pharma AG Announces Adjustment of Guidance
PDF
14 September 2020
PR: Heidelberg Pharma Receives Milestone Payment from Partner Magenta
PDF
10 September 2020
PR: Heidelberg Pharma Announces Participation at Various Conferences
PDF
22 July 2020
PR: Annual General Meeting 2020 of Heidelberg Pharma Approves All Proposed Resolutions
PDF
21 July 2020
AH: Heidelberg Pharma AG: Main Shareholder dievini Commits to Further Financing for Expansion of Proprietary Pipeline
PDF
09 July 2020
PR: Heidelberg Pharma reports on first half-year 2020
PDF
24 June 2020
PR: Heidelberg Pharma to Present at the Upcoming Virtual European Biotech Investor Day 2020
PDF
27 April 2020
AH: Heidelberg Pharma AG Plans Capital Increase to Fund Its ATAC Development Program
PDF
27 April 2020
AH: Heidelberg Pharma AG Raises EUR 14.4 Million From Private Placement
PDF
23 April 2020
PR: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2020
PDF
31 March 2020
PR: Heidelberg Pharma AG: European Patent Office Grants Patent for Amatoxin Conjugates for Tumor Therapy
PDF
26 March 2020
PR: Heidelberg Pharma Publishes Article on Chemical Amanitin Synthesis in Angewandte Chemie Journal
PDF
19 March 2020
PR: Heidelberg Pharma Announces Financial Figures for Fiscal Year 2019 and Provides Business Update
PDF
04 March 2020
PR: Heidelberg Pharma AG: US patent rights granted for diagnosis and treatment of patients with TP53/RNA polymerase II deletion
PDF
24 February 2020
PR: Partner Magenta Therapeutics Presents Preclinical Data on Lead Clinical Candidate MGTA-117 Demonstrating Broad Tolerability and High Therapeutic Index
PDF
22 January 2020
AH: Heidelberg Pharma AG Secures Financing Commitment from Its Main Shareholder dievini
PDF